H.R. 3026 (112th): Safeguarding America’s Pharmaceuticals Act of 2011
Sep 22, 2011
112th Congress, 2011–2013
Died in a previous Congress
This bill was introduced on September 22, 2011, in a previous session of Congress, but was not enacted.
Representative for Utah's 2nd congressional district
Read Text »
Last Updated: Sep 22, 2011
Length: 33 pages
About the bill
- Full Title
To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs.
- What is a bill?
The “H.R.” in “H.R. 3026” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 3026 — 112th Congress: Safeguarding America’s Pharmaceuticals Act of 2011. Retrieved from https://www.govtrack.us/congress/bills/112/hr3026
“H.R. 3026 — 112th Congress: Safeguarding America’s Pharmaceuticals Act of 2011.” www.GovTrack.us. 2011. April 18, 2015 <https://www.govtrack.us/congress/bills/112/hr3026>
|title=H.R. 3026 (112th)
|accessdate=April 18, 2015
|author=112th Congress (2011)
|date=September 22, 2011
|quote=Safeguarding America’s Pharmaceuticals Act of 2011